FDA Launches IND Pilot to Speed Up Appointments
The U.S. FDA announced the final design of the new Expedited Investigational New Drug Pilot and began accepting applications.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day